Viewing Study NCT04796194


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2025-12-27 @ 11:09 PM
Study NCT ID: NCT04796194
Status: COMPLETED
Last Update Posted: 2025-11-20
First Post: 2021-03-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma
Sponsor: Lytix Biopharma AS
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module